[{"Assets_0_Q2_USD":274382000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":49641000.0,"NetIncomeLoss_1_Q2_USD":18196000.0,"NetIncomeLoss_2_Q2_USD":35655000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":127515000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":127610000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":115492000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":115189000.0,"StockholdersEquity_0_Q2_USD":243509000.0,"EarningsPerShareBasic_1_Q2_USD":0.16,"EarningsPerShareBasic_2_Q2_USD":0.31,"EarningsPerShareDiluted_1_Q2_USD":0.14,"EarningsPerShareDiluted_2_Q2_USD":0.28,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":62312000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":119971000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]